Osteoporosis is an underdiagnosed disease. Patients with circumscribed risk factors should not be deprived of a bone density measurement. Although osteoporosis cannot be completely cured, its progression can be delayed with effective treatment. The current guideline defines treatment indication thresholds for the use of specific osteoporosis drugs (antiresorptives, osteoanabolics). In general, treatment should be tailored to the patient’s individual situation.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- "Patients W.A.I.T. Indicator"
Access to new drugs is becoming increasingly difficult
- Cardiometabolic research
The liver-heart axis in the pathogenesis of cardiometabolic diseases
- ASCO 2025
Supportive therapies for greater adherence and compliance
- Heart rhythm
From harmonious symphony to age-related dissonance
- Precision therapy
Targeted MET inhibition after progression with osimertinib
- Chronic cough
Differential diagnostic detective work and trial therapies
- Cancer in Europe: facts and analysis
New Health Policy Report published
- Glomerulonephritis: IgA nephropathy